1. Home
  2. HLNE vs ALKS Comparison

HLNE vs ALKS Comparison

Compare HLNE & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hamilton Lane Incorporated

HLNE

Hamilton Lane Incorporated

HOLD

Current Price

$96.73

Market Cap

4.7B

Sector

Finance

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$27.85

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLNE
ALKS
Founded
1991
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
5.5B
IPO Year
2017
2012

Fundamental Metrics

Financial Performance
Metric
HLNE
ALKS
Price
$96.73
$27.85
Analyst Decision
Buy
Buy
Analyst Count
9
14
Target Price
$168.33
$43.43
AVG Volume (30 Days)
871.0K
1.8M
Earning Date
05-04-2026
05-22-2026
Dividend Yield
2.29%
N/A
EPS Growth
41.64
N/A
EPS
3.98
1.43
Revenue
$712,963,000.00
$1,475,899,000.00
Revenue This Year
$9.81
$24.06
Revenue Next Year
$19.69
$4.53
P/E Ratio
$23.64
$19.34
Revenue Growth
28.73
N/A
52 Week Low
$92.77
$25.17
52 Week High
$179.19
$36.32

Technical Indicators

Market Signals
Indicator
HLNE
ALKS
Relative Strength Index (RSI) 29.03 28.48
Support Level N/A $25.65
Resistance Level $157.95 $28.75
Average True Range (ATR) 4.59 1.10
MACD -0.19 -0.33
Stochastic Oscillator 21.33 7.74

Price Performance

Historical Comparison
HLNE
ALKS

About HLNE Hamilton Lane Incorporated

Hamilton Lane Inc is a private markets investment firm globally, providing solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 750 professionals operating in offices throughout North America, Europe, Asia Pacific, and the Middle East. It has approximately $986 billion in assets under management and supervision, composed of nearly $141 billion in discretionary assets and more than $845 billion in non-discretionary assets. The group specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors, and geographies.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: